Progressive In-Vivo Development of resistance to cefiderocol in P. aeruginosa

NIAID Data Ecosystem2026-03-13 收录

细菌耐药性演化

抗感染药物

数据链接：

https://www.ncbi.nlm.nih.gov/bioproject/PRJNA856996 数据链接链接失效反馈

官方服务：

资源简介：

Progressive In-Vivo Development of resistance to cefiderocol in P. aeruginosa

创建时间：

2022-07-08

抗感染药物数据库

抗感染药物

临床用药

为抗感染药临床用药数据，包括病例情况：总例数、治疗组例数、对照组例数、性别例数、年龄区间、平均年龄、疾病、并发症等；用药情况：用药目的、用法用量、联合用药等；药品情况：药品名称、药品英文名称、商品名、剂型、规格、生产厂家、批准文号、分类等；药物疗效：疗效评判标准、疗效及用药前后临床指征比较等；药物不良反应情况。适用于药物研发、科研教育、医疗卫生和政府管理等方面。

中国科技资源共享网2026-06-29 更新140

Selectivity Modulation of Small Cationic Membrane-Active Cyclic Peptides with Broad-Spectrum Activity against Bacteria and Fungi

抗菌肽设计

抗感染药物

To investigate how ring size and backbone flexibility influence antimicrobial potency and cytotoxicity, we synthesized a series of macrocyclic peptides of lead peptide p1 (c[Arg-Arg-arg-arg-dip-Trp-di

NIAID Data Ecosystem30

Tinidazole Tablet Market

药物市场研究

抗感染药物

The report offers Tinidazole Tablet Market Dynamics, Comprises Industry development drivers, challenges, opportunities, threats and limitations. A report also incorporates Cost Trend of products, Merg

IMR REPORTS10

Comparative IC 50 of meglumine antimoniate and 2HF against L . amazonensis -infected macrophages using wild-type and antimony-resistant L . amazonensis promastigotes.

利什曼原虫耐药性

抗感染药物

Comparative IC50 of meglumine antimoniate and 2HF against L. amazonensis-infected macrophages using wild-type and antimony-resistant L. amazonensis promastigotes.

NIAID Data Ecosystem30

North America Farm Animal Anti Infective Medicine Market

兽药市场分析

抗感染药物

The North America Farm Animal Anti Infective Medicine market report offers a thorough competitive analysis, mapping key players’ strategies, market share, and business models. It provides insights int

IMR REPORTS20

Progressive In-Vivo Development of resistance to cefiderocol in P. aeruginosa

资源简介：

相关数据集